Spyre Therapeutics Inc (SYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -208,018 | -151,722 | -82,694 | -43,857 | -338,790 |
| Depreciation Amortization | N/A | N/A | N/A | N/A | 964 |
| Accounts receivable | N/A | N/A | N/A | N/A | 375 |
| Accounts payable and accrued liabilities | -230 | 4,268 | 2,335 | 2,210 | 218 |
| Other Working Capital | -4,534 | -15,332 | -25,683 | 3,473 | -5,206 |
| Other Operating Activity | 55,372 | 42,575 | 15,252 | 9,632 | 242,529 |
| Operating Cash Flow | $-157,410 | $-120,211 | $-90,790 | $-28,542 | $-99,910 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -353,285 | -182,741 | -225,481 | -104,963 | -126,903 |
| PPE Investments | N/A | N/A | N/A | N/A | 475 |
| Net Acquisitions | N/A | N/A | N/A | N/A | 3,035 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 15,000 |
| Investing Cash Flow | $-353,285 | $-182,741 | $-225,481 | $-104,963 | $-108,393 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 243,892 | 17,963 | 4,885 | 4,390 | 84,960 |
| Other Financing Activity | 167,014 | 167,342 | 167,640 | 167,775 | 276,117 |
| Financing Cash Flow | $410,906 | $185,305 | $172,525 | $172,165 | $361,077 |
| Exchange Rate Effect | -3 | 12 | -4 | -4 | 25 |
| Beginning Cash Position | 189,215 | 189,215 | 189,215 | 189,215 | 36,416 |
| End Cash Position | 89,423 | 71,580 | 45,465 | 227,871 | 189,215 |
| Net Cash Flow | $-99,792 | $-117,635 | $-143,750 | $38,656 | $152,799 |
| Free Cash Flow | |||||
| Operating Cash Flow | -157,410 | -120,211 | -90,790 | -28,542 | -99,910 |
| Free Cash Flow | -157,410 | -120,211 | -90,790 | -28,542 | -99,910 |